Direct-to-Consumer Genetic Testing Market Growth, Size, Trends, Share, Scope and Future Outlook
Direct-to-Consumer (DTC) Genetic Testing Market Size- By Sales Channel, By Service, By Test type, By Technology, By End user- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: May-2024 | Report ID: HLCA2457 | Pages: 1 - 228 | Formats*: |
| Category : Healthcare | |||
Direct-to-Consumer (DTC) Genetic Testing Market Introduction and Overview
According to SPER Market Research, the Global Direct-to-Consumer (DTC) Genetic Testing Market is estimated to reach USD 5504.35 million by 2033 with a CAGR of 12.36%.
The report includes an in-depth analysis of the Global Direct-to-Consumer (DTC) Genetic Testing Market, including market size and trends, product mix, applications, and supplier analysis. Genetic tests are sold directly to consumers via a variety of marketing channels in direct-to-consumer (DTC) genetic testing. Customers buy a testing kit, take a DNA sample (usually with a cheek swab or saliva sample), and send it to a lab. The consumer receives direct results from the laboratory after the DNA analysis, frequently via an internet platform. Ancestry, genetic susceptibilities to certain diseases, carrier status for hereditary disorders, and a variety of individual characteristics like physical attributes or level of fitness can all be discovered through these tests. Without involving medical professionals, this direct access enables people to learn more about their genetic background and potential health concerns.
- MARCH 2021; 23andMe announced in March 2021 that it would merge with VG Acquisition Corp., a special purpose acquisition company (SPAC), in order to go public. The purpose of the merger was to increase the company's consumer health offerings and hasten its growth.
- FEBRUARY 2021; Leading genealogy and genetic testing company My Heritage unveiled My Heritage Health, a new offering, in February 2021. It gave users a thorough understanding of their genetic heritage and health risks by combining family history research with genetic testing.
%20Genetic%20Testing%20Market%20%201-008480024052024.webp)
Market Opportunities and Challenges
The market for DTC genetic testing is fuelled by a number of important factors. Demand for genetic insights that can guide lifestyle and medical decisions has increased due to growing consumer interest in personalized health and wellness. Thanks to technological advancements, genetic testing is now much more affordable and available to a wider range of people. Customers looking for quick and easy access to their genetic information are drawn to the ease of use of at-home testing kits and the convenience of online shopping. Increasing awareness and interest has also been greatly aided by marketing initiatives, especially those carried out online and on social media platforms. Among the many difficulties facing the DTC genetic testing market are questions regarding the dependability and accuracy of test results, which can differ amongst providers. Because genetic information about consumers may be misused or shared without authorization, privacy concerns are important. Without expert assistance, customers may also misinterpret the results, which could cause needless worry or misleading comfort. Inconsistent ethical and quality standards can also result from the industry's lack of regulation and standardization.
%20Genetic%20Testing%20Market%20%202-008481024052024.webp)
Market Competitive Landscape
The DTC genetic testing market is characterized by intense and ever-changing competition. Many businesses compete for market share by providing a variety of genetic testing services, such as health risk assessments and ancestry tracking. The major players in the market are Ancestry(US), 23andMe, Inc. (USA), Color Health, IncDante Labs, Inc., (US), EasyDNA(USA), Full Genomes Corporation, Inc.(US), Gene by Gene, Ltd.(US), Genesis HealthCare(US), Helix OpCo LLC(US), Living DNA Ltd (UK), others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Sales Channel, By Service, By Test type, By Technology, By End user |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Ancestry(US), 23andMe, Inc. (USA), Color Health, IncDante Labs, Inc., (US), EasyDNA(USA), Full Genomes Corporation, Inc.(US), Gene by Gene, Ltd.(US), Genesis HealthCare(US), Helix OpCo LLC(US), Living DNA Ltd (UK) Others |
COVID-19 Impact on Global Direct-to-Consumer (DTC) Genetic Testing Market
The DTC genetic testing market was affected by the COVID-19 pandemic in a variety of ways. On the one hand, processing and delivering test results were delayed due to supply chain disruptions and temporary lab closures. However, the pandemic's increased emphasis on wellness and health sparked consumer curiosity about hereditary susceptibilities to illnesses, including infection-related diseases. The popularity of at-home testing kits increased with the emergence of online and remote services, as consumers looked for easy ways to obtain health information without going to medical facilities.
Key Target Audience:
- Investors and Financial Analysts
- Healthcare Professionals
- Genetic Testing Companies
- Market Researchers
- Policy Makers and Regulators
- Consumer Advocacy Groups
- Technology and Innovation Specialists
Our in-depth analysis of the Direct-to-Consumer (DTC) Genetic Testing Market includes the following segments:
| By Sales channels: |
|
| By Service: |
|
| By Test Type: |
|
| By Technology: |
|
| By End User: |
|
Key Topics Covered in the Report:
- Global Direct-to-Consumer (DTC) Genetic Testing Market (FY’2024-FY’2033)
- Overview of Global Direct-to-Consumer (DTC) Genetic Testing Market
- Segmentation of Global Direct-to-Consumer (DTC) Genetic Testing Market By Sales Channel (Online Sales, OTC Sales and Doctor's Office)
- Segmentation of Global Direct-to-Consumer (DTC) Genetic Testing Market By Service (Diagnostic Screening, Prenatal, New-born Screening, Pre-Implantation Diagnosis and Relationship Testing)
- Segmentation of Global Direct-to-Consumer (DTC) Genetic Testing Market By Test Type (Carrier Testing, Predictive Testing, Ancestry and Relationship Testing)
- Segmentation of Global Direct-to-Consumer (DTC) Genetic Testing Market By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips and Whole Genome Sequencing (WGS))
- Segmentation of Global Direct-to-Consumer (DTC) Genetic Testing Market By End User (Laboratories, Blood Banks, Nursing Home)
- Statistical Snap of Global Direct-to-Consumer (DTC) Genetic Testing Market
- Expansion Analysis of Global Direct-to-Consumer (DTC) Genetic Testing Market
- Problems and Obstacles in Global Direct-to-Consumer (DTC) Genetic Testing Market
- Competitive Landscape in the Global Direct-to-Consumer (DTC) Genetic Testing Market
- Impact of COVID-19 and Demonetization on Global Direct-to-Consumer (DTC) Genetic Testing Market
- Details on Current Investment in Global Direct-to-Consumer (DTC) Genetic Testing Market
- Competitive Analysis of Global Direct-to-Consumer (DTC) Genetic Testing Market
- Prominent Players in the Global Direct-to-Consumer (DTC) Genetic Testing Market
- SWOT Analysis of Global Direct-to-Consumer (DTC) Genetic Testing Market
- Global Direct-to-Consumer (DTC) Genetic Testing Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
4.2. COVID-19 Impacts of the Direct-to-Consumer (DTC) Genetic Testing Market.
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Surgical Drains Market
7. Global Surgical Drains Market, By Sales channels (USD Million) 2020-2033
7.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Sales Channel, 2020-20267.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Sales Channel, 2027-20337.3. Online Sales7.4. OTC Sales
8. Global Direct-to-Consumer (DTC) Genetic Testing Market, By Service (USD Million) 2020-2033
8.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Service, 2020-20268.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Service, 2027-20338.3. Diagnostic Screening8.4. Prenatal8.5. New-born Screening8.6. Pre-Implantation Diagnosis8.7. Relationship Testing
9. Global Direct-to-Consumer (DTC) Genetic Testing Market, By Test Type (USD Million) 2020-2033
9.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Test Type, 2020-20269.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Test Type, 2027-20339.3. Carrier Testing9.4. Predictive Testing9.5. Ancestry9.6. Relationship Testing
10. Global Direct-to-Consumer (DTC) Genetic Testing Market, By Technology (USD Million) 2020-2033
10.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Technology, 2020-202610.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Technology, 2027-203310.3. Targeted Analysis10.4. Single Nucleotide Polymorphism chips10.5. Whole Genome Sequencing
11. Global Direct-to-Consumer (DTC) Genetic Testing Market, By End User (USD Million) 2020-2033
11.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By End-User, 2020-202611.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By End-User, 2027-203311.3. Laboratories11.4. Blood Banks11.5. Nursing Homes11.6. Hospitals11.7. Home Care
12. Global Direct-to-Consumer (DTC) Genetic Testing Market Forecast, 2020-2033 (USD Million)
12.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size and Market Share
13. Global Direct-to-Consumer (DTC) Genetic Testing Market, By Region, 2020-2033 (USD Million)
13.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Share By Region (2020-2026)13.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Share By Region (2027-2033)13.3. Asia-Pacific13.3.1. Australia13.3.2. China13.3.3. India13.3.4. Japan13.3.5. South Korea13.3.6. Rest of Asia-Pacific13.4. Europe13.4.1. France13.4.2. Germany13.4.3. Italy13.4.4. Spain13.4.5. United Kingdom13.4.6. Rest of Europe13.5. Middle East and Africa13.5.1. Kingdom of Saudi Arabia13.5.2. United Arab Emirates13.5.3. Qatar13.5.4. South Africa13.5.5. Egypt13.5.6. Morocco13.5.7. Nigeria13.5.8. Rest of Middle-East and Africa13.6. North America13.6.1. Canada13.6.2. Mexico13.6.3. United States13.7. Latin America13.7.1. Argentina13.7.2. Brazil13.7.3. Rest of Latin America
14. Company Profile
14.1. Ancestry(US)14.1.1. Company details14.1.2. Financial outlook14.1.3. Product summary14.1.4. Recent developments14.2. 23andMe, Inc. (USA)14.2.1. Company details14.2.2. Financial outlook14.2.3. Product summary14.2.4. Recent developments14.3. Color Health, Inc.(US)14.3.1. Company details14.3.2. Financial outlook14.3.3. Product summary
14.3.4. Recent developments
14.4. Dante Labs, Inc., (US)14.4.1. Company details14.4.2. Financial outlook14.4.3. Product summary14.4.4. Recent developments14.5. EasyDNA(USA)14.5.1. Company details14.5.2. Financial outlook14.5.3. Product summary14.5.4. Recent developments14.6. Full Genomes Corporation, Inc.(US)14.6.1. Company details14.6.2. Financial outlook14.6.3. Product summary14.6.4. Recent developments14.7. Gene by Gene, Ltd.(US)14.7.1. Company details14.7.2. Financial outlook14.7.3. Product summary14.7.4. Recent developments14.8. Genesis HealthCare(US)14.8.1. Company details14.8.2. Financial outlook14.8.3. Product summary14.8.4. Recent developments14.9. Helix OpCo LLC(US)14.9.1. Company details14.9.2. Financial outlook14.9.3. Product summary14.9.4. Recent developments14.10. Living DNA Ltd (UK)14.10.1. Company details14.10.2. Financial outlook14.10.3. Product summary14.10.4. Recent developments14.11. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
"The key players in the market include Companies Covered Ancestry(US), 23andMe, Inc. (USA), Color Health, IncDante Labs, Inc., (US), EasyDNA(USA), Full Genomes Corporation, Inc.(US), Gene by Gene, Ltd.(US), Genesis HealthCare(US), Helix OpCo LLC(US), Living DNA Ltd (UK) Others.
"
Ancestry, genetic susceptibilities to certain diseases, carrier status for hereditary disorders, and a variety of individual characteristics.
Direct-to-Consumer (DTC) Genetic Testing Market is projected to reach USD 5504.35 million by 2033, growing at a CAGR of 12.36% during the forecast period.
Direct-to-Consumer (DTC) Genetic Testing Market size from 2022. The Market is expected to reach USD 5504.35 million by 2033, at a CAGR of 12.36% during the forecast period.
Direct-to-Consumer (DTC) Genetic Testing Market CAGR of 12.36% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Direct-to-Consumer (DTC) Genetic Testing Market size is 5504.35 million from 2024 to 2033.
Direct-to-Consumer (DTC) Genetic Testing Market Segment is covered By Sales Channel, By Service, By Test type, By Technology, By End user.
The North America anticipated to have the highest market share in the Direct-to-Consumer (DTC) Genetic Testing Market.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
